Literature DB >> 22991262

Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents.

O T Hardy1, A Kim, C Ciccarelli, L L Hayman, J Wiecha.   

Abstract

BACKGROUND: Metabolic syndrome (MetSyn) is diagnosed frequently in some but not all overweight adolescents. Chronic inflammation, as seen in obesity, is strongly associated with MetSyn.
OBJECTIVES: The aim of this pilot study was to assess the correlation between activation of the innate immune system and MetSyn, independent of body mass index (BMI), in a young population.
METHODS: We quantitatively measured both systemic pro-inflammatory cytokines and gene expression of Toll-like receptors (TLRs) and downstream cytokines in circulating monocytes obtained from nine adolescents with metabolic syndrome (Overwt-MetSyn) and eight BMI-matched controls (Overwt-Healthy).
RESULTS: The Overwt-MetSyn group demonstrated a significant elevation in expression of TLR2, TLR4, tumour necrosis factor-a (TNF a) and interleukin-6 (IL6) in peripheral monocytes, and increased circulating levels of TNF a and IL6 when compared with the Overwt-Healthy group. TLR2 (r = 0.78, P < 0.001), TLR4 (r = 0.57, P < 0.01) and TNF a (r = 0.61, P < 0.01) gene expression positively correlated with serum levels of TNF a.
CONCLUSIONS: Our study suggests that activation of the innate immune pathway via TLRs may be partially responsible for the increased systemic inflammation seen in adolescents with MetSyn.
© 2012 The Authors. Pediatric Obesity © 2012 International Association for the Study of Obesity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991262      PMCID: PMC3546604          DOI: 10.1111/j.2047-6310.2012.00098.x

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  19 in total

1.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

Authors:  Hanna-Maaria Lakka; David E Laaksonen; Timo A Lakka; Leo K Niskanen; Esko Kumpusalo; Jaakko Tuomilehto; Jukka T Salonen
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

2.  Expression of inflammatory molecules and associations with BMI in children.

Authors:  George V Z Dedoussis; Alexandra Kapiri; Anastasia Samara; Dimitris Dimitriadis; Daniel Lambert; Michele Pfister; Gerard Siest; Sophie Visvikis-Siest
Journal:  Eur J Clin Invest       Date:  2010-03-25       Impact factor: 4.686

3.  Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes.

Authors:  Jeremy E Davis; Douglas R Braucher; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  J Nutr Biochem       Date:  2011-02       Impact factor: 6.048

4.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

5.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

6.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Components of the "metabolic syndrome" and incidence of type 2 diabetes.

Authors:  Robert L Hanson; Giuseppina Imperatore; Peter H Bennett; William C Knowler
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

9.  Increased toll-like receptor activity in patients with metabolic syndrome.

Authors:  Ishwarlal Jialal; Beverley A Huet; Harmeet Kaur; Alexander Chien; Sridevi Devaraj
Journal:  Diabetes Care       Date:  2012-02-22       Impact factor: 19.112

10.  Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Authors:  Mohan R Dasu; Sridevi Devaraj; Samuel Park; Ishwarlal Jialal
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more
  12 in total

1.  Gene expression profiling and association of circulating lactoferrin level with obesity-related phenotypes in Latino youth.

Authors:  J Y Kim; L E Campbell; G Q Shaibi; D K Coletta
Journal:  Pediatr Obes       Date:  2014-11-14       Impact factor: 4.000

2.  Effects of endurance exercise training on inflammatory circulating progenitor cell content in lean and obese adults.

Authors:  Grace M Niemiro; Jacob M Allen; Lucy J Mailing; Naiman A Khan; Hannah D Holscher; Jeffrey A Woods; Michael De Lisio
Journal:  J Physiol       Date:  2018-06-19       Impact factor: 5.182

3.  Adipocytes as immune regulatory cells.

Authors:  Silvana A Vielma; Richard L Klein; Corinne A Levingston; M Rita I Young
Journal:  Int Immunopharmacol       Date:  2013-04-13       Impact factor: 4.932

4.  The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.

Authors:  R Pahwa; S Devaraj; I Jialal
Journal:  Int J Obes (Lond)       Date:  2016-02-16       Impact factor: 5.095

Review 5.  Innate immunity in diabetes and diabetic nephropathy.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

Review 6.  Perspectives for Monocyte/Macrophage-Based Diagnostics of Chronic Inflammation.

Authors:  Julia Kzhyshkowska; Alexandru Gudima; Kondaiah Moganti; Alexei Gratchev; Alexander Orekhov
Journal:  Transfus Med Hemother       Date:  2016-03-15       Impact factor: 3.747

7.  A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway.

Authors:  Anand R Nair; Carrie M Elks; Jorge Vila; Fabio Del Piero; Daniel B Paulsen; Joseph Francis
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

8.  Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study.

Authors:  Lena Leder; Marjukka Kolehmainen; Ingunn Narverud; Ingrid Dahlman; Mari C W Myhrstad; Vanessa D de Mello; Jussi Paananen; Carsten Carlberg; Ursula Schwab; Karl-Heinz Herzig; Lieselotte Cloetens; Matilda Ulmius Storm; Janne Hukkanen; Markku J Savolainen; Fredrik Rosqvist; Kjeld Hermansen; Lars O Dragsted; Ingibjörg Gunnarsdottir; Inga Thorsdottir; Ulf Risérus; Björn Åkesson; Magne Thoresen; Peter Arner; Kaisa S Poutanen; Matti Uusitupa; Kirsten B Holven; Stine M Ulven
Journal:  Genes Nutr       Date:  2016-03-17       Impact factor: 5.523

9.  Intestinal epithelial Toll-like receptor 4 prevents metabolic syndrome by regulating interactions between microbes and intestinal epithelial cells in mice.

Authors:  P Lu; C P Sodhi; Y Yamaguchi; H Jia; T Prindle; W B Fulton; A Vikram; K J Bibby; M J Morowitz; D J Hackam
Journal:  Mucosal Immunol       Date:  2018-01-24       Impact factor: 7.313

10.  Supplementation of Juçara Berry (Euterpe edulis Mart.) Modulates Epigenetic Markers in Monocytes from Obese Adults: A Double-Blind Randomized Trial.

Authors:  Aline Boveto Santamarina; Giovana Jamar; Laís Vales Mennitti; Helena de Cássia César; Verdiana Vera de Rosso; José Ronnie Vasconcelos; Lila Missae Oyama; Luciana Pellegrini Pisani
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.